Global Muscle Relaxers Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
1 Market Overview
- 1.1 Product Overview and Scope of Muscle Relaxers
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Muscle Relaxers Consumption Value by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Tablet
- 1.3.3 Capsule
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Muscle Relaxers Consumption Value by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Pharmacy
- 1.5 Global Muscle Relaxers Market Size & Forecast
- 1.5.1 Global Muscle Relaxers Consumption Value (2018 & 2022 & 2029)
- 1.5.2 Global Muscle Relaxers Sales Quantity (2018-2029)
- 1.5.3 Global Muscle Relaxers Average Price (2018-2029)
2 Manufacturers Profiles
- 2.1 Novartis
- 2.1.1 Novartis Details
- 2.1.2 Novartis Major Business
- 2.1.3 Novartis Muscle Relaxers Product and Services
- 2.1.4 Novartis Muscle Relaxers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 Novartis Recent Developments/Updates
- 2.2 Viatris
- 2.2.1 Viatris Details
- 2.2.2 Viatris Major Business
- 2.2.3 Viatris Muscle Relaxers Product and Services
- 2.2.4 Viatris Muscle Relaxers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Viatris Recent Developments/Updates
- 2.3 Teva Pharmaceuticals
- 2.3.1 Teva Pharmaceuticals Details
- 2.3.2 Teva Pharmaceuticals Major Business
- 2.3.3 Teva Pharmaceuticals Muscle Relaxers Product and Services
- 2.3.4 Teva Pharmaceuticals Muscle Relaxers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Teva Pharmaceuticals Recent Developments/Updates
- 2.4 Endo Pharmaceuticals
- 2.4.1 Endo Pharmaceuticals Details
- 2.4.2 Endo Pharmaceuticals Major Business
- 2.4.3 Endo Pharmaceuticals Muscle Relaxers Product and Services
- 2.4.4 Endo Pharmaceuticals Muscle Relaxers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Endo Pharmaceuticals Recent Developments/Updates
- 2.5 Mayne Pharma
- 2.5.1 Mayne Pharma Details
- 2.5.2 Mayne Pharma Major Business
- 2.5.3 Mayne Pharma Muscle Relaxers Product and Services
- 2.5.4 Mayne Pharma Muscle Relaxers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Mayne Pharma Recent Developments/Updates
- 2.6 Merck & Co. Inc
- 2.6.1 Merck & Co. Inc Details
- 2.6.2 Merck & Co. Inc Major Business
- 2.6.3 Merck & Co. Inc Muscle Relaxers Product and Services
- 2.6.4 Merck & Co. Inc Muscle Relaxers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Merck & Co. Inc Recent Developments/Updates
- 2.7 GSK
- 2.7.1 GSK Details
- 2.7.2 GSK Major Business
- 2.7.3 GSK Muscle Relaxers Product and Services
- 2.7.4 GSK Muscle Relaxers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 GSK Recent Developments/Updates
- 2.8 Casper Pharma LLC
- 2.8.1 Casper Pharma LLC Details
- 2.8.2 Casper Pharma LLC Major Business
- 2.8.3 Casper Pharma LLC Muscle Relaxers Product and Services
- 2.8.4 Casper Pharma LLC Muscle Relaxers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 Casper Pharma LLC Recent Developments/Updates
- 2.9 Bayer
- 2.9.1 Bayer Details
- 2.9.2 Bayer Major Business
- 2.9.3 Bayer Muscle Relaxers Product and Services
- 2.9.4 Bayer Muscle Relaxers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 Bayer Recent Developments/Updates
- 2.10 BASF
- 2.10.1 BASF Details
- 2.10.2 BASF Major Business
- 2.10.3 BASF Muscle Relaxers Product and Services
- 2.10.4 BASF Muscle Relaxers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.10.5 BASF Recent Developments/Updates
- 2.11 ADVIL
- 2.11.1 ADVIL Details
- 2.11.2 ADVIL Major Business
- 2.11.3 ADVIL Muscle Relaxers Product and Services
- 2.11.4 ADVIL Muscle Relaxers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.11.5 ADVIL Recent Developments/Updates
- 2.12 Pfizer
- 2.12.1 Pfizer Details
- 2.12.2 Pfizer Major Business
- 2.12.3 Pfizer Muscle Relaxers Product and Services
- 2.12.4 Pfizer Muscle Relaxers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.12.5 Pfizer Recent Developments/Updates
- 2.13 Johnson & Johnson
- 2.13.1 Johnson & Johnson Details
- 2.13.2 Johnson & Johnson Major Business
- 2.13.3 Johnson & Johnson Muscle Relaxers Product and Services
- 2.13.4 Johnson & Johnson Muscle Relaxers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.13.5 Johnson & Johnson Recent Developments/Updates
- 2.14 Rosemont Pharmaceuticals
- 2.14.1 Rosemont Pharmaceuticals Details
- 2.14.2 Rosemont Pharmaceuticals Major Business
- 2.14.3 Rosemont Pharmaceuticals Muscle Relaxers Product and Services
- 2.14.4 Rosemont Pharmaceuticals Muscle Relaxers Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
- 2.14.5 Rosemont Pharmaceuticals Recent Developments/Updates
3 Competitive Environment: Muscle Relaxers by Manufacturer
- 3.1 Global Muscle Relaxers Sales Quantity by Manufacturer (2018-2023)
- 3.2 Global Muscle Relaxers Revenue by Manufacturer (2018-2023)
- 3.3 Global Muscle Relaxers Average Price by Manufacturer (2018-2023)
- 3.4 Market Share Analysis (2022)
- 3.4.1 Producer Shipments of Muscle Relaxers by Manufacturer Revenue ($MM) and Market Share (%): 2022
- 3.4.2 Top 3 Muscle Relaxers Manufacturer Market Share in 2022
- 3.4.2 Top 6 Muscle Relaxers Manufacturer Market Share in 2022
- 3.5 Muscle Relaxers Market: Overall Company Footprint Analysis
- 3.5.1 Muscle Relaxers Market: Region Footprint
- 3.5.2 Muscle Relaxers Market: Company Product Type Footprint
- 3.5.3 Muscle Relaxers Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Muscle Relaxers Market Size by Region
- 4.1.1 Global Muscle Relaxers Sales Quantity by Region (2018-2029)
- 4.1.2 Global Muscle Relaxers Consumption Value by Region (2018-2029)
- 4.1.3 Global Muscle Relaxers Average Price by Region (2018-2029)
- 4.2 North America Muscle Relaxers Consumption Value (2018-2029)
- 4.3 Europe Muscle Relaxers Consumption Value (2018-2029)
- 4.4 Asia-Pacific Muscle Relaxers Consumption Value (2018-2029)
- 4.5 South America Muscle Relaxers Consumption Value (2018-2029)
- 4.6 Middle East and Africa Muscle Relaxers Consumption Value (2018-2029)
5 Market Segment by Type
- 5.1 Global Muscle Relaxers Sales Quantity by Type (2018-2029)
- 5.2 Global Muscle Relaxers Consumption Value by Type (2018-2029)
- 5.3 Global Muscle Relaxers Average Price by Type (2018-2029)
6 Market Segment by Application
- 6.1 Global Muscle Relaxers Sales Quantity by Application (2018-2029)
- 6.2 Global Muscle Relaxers Consumption Value by Application (2018-2029)
- 6.3 Global Muscle Relaxers Average Price by Application (2018-2029)
7 North America
- 7.1 North America Muscle Relaxers Sales Quantity by Type (2018-2029)
- 7.2 North America Muscle Relaxers Sales Quantity by Application (2018-2029)
- 7.3 North America Muscle Relaxers Market Size by Country
- 7.3.1 North America Muscle Relaxers Sales Quantity by Country (2018-2029)
- 7.3.2 North America Muscle Relaxers Consumption Value by Country (2018-2029)
- 7.3.3 United States Market Size and Forecast (2018-2029)
- 7.3.4 Canada Market Size and Forecast (2018-2029)
- 7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
- 8.1 Europe Muscle Relaxers Sales Quantity by Type (2018-2029)
- 8.2 Europe Muscle Relaxers Sales Quantity by Application (2018-2029)
- 8.3 Europe Muscle Relaxers Market Size by Country
- 8.3.1 Europe Muscle Relaxers Sales Quantity by Country (2018-2029)
- 8.3.2 Europe Muscle Relaxers Consumption Value by Country (2018-2029)
- 8.3.3 Germany Market Size and Forecast (2018-2029)
- 8.3.4 France Market Size and Forecast (2018-2029)
- 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
- 8.3.6 Russia Market Size and Forecast (2018-2029)
- 8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
- 9.1 Asia-Pacific Muscle Relaxers Sales Quantity by Type (2018-2029)
- 9.2 Asia-Pacific Muscle Relaxers Sales Quantity by Application (2018-2029)
- 9.3 Asia-Pacific Muscle Relaxers Market Size by Region
- 9.3.1 Asia-Pacific Muscle Relaxers Sales Quantity by Region (2018-2029)
- 9.3.2 Asia-Pacific Muscle Relaxers Consumption Value by Region (2018-2029)
- 9.3.3 China Market Size and Forecast (2018-2029)
- 9.3.4 Japan Market Size and Forecast (2018-2029)
- 9.3.5 Korea Market Size and Forecast (2018-2029)
- 9.3.6 India Market Size and Forecast (2018-2029)
- 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
- 9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
- 10.1 South America Muscle Relaxers Sales Quantity by Type (2018-2029)
- 10.2 South America Muscle Relaxers Sales Quantity by Application (2018-2029)
- 10.3 South America Muscle Relaxers Market Size by Country
- 10.3.1 South America Muscle Relaxers Sales Quantity by Country (2018-2029)
- 10.3.2 South America Muscle Relaxers Consumption Value by Country (2018-2029)
- 10.3.3 Brazil Market Size and Forecast (2018-2029)
- 10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
- 11.1 Middle East & Africa Muscle Relaxers Sales Quantity by Type (2018-2029)
- 11.2 Middle East & Africa Muscle Relaxers Sales Quantity by Application (2018-2029)
- 11.3 Middle East & Africa Muscle Relaxers Market Size by Country
- 11.3.1 Middle East & Africa Muscle Relaxers Sales Quantity by Country (2018-2029)
- 11.3.2 Middle East & Africa Muscle Relaxers Consumption Value by Country (2018-2029)
- 11.3.3 Turkey Market Size and Forecast (2018-2029)
- 11.3.4 Egypt Market Size and Forecast (2018-2029)
- 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
- 11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
- 12.1 Muscle Relaxers Market Drivers
- 12.2 Muscle Relaxers Market Restraints
- 12.3 Muscle Relaxers Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
- 12.5 Influence of COVID-19 and Russia-Ukraine War
- 12.5.1 Influence of COVID-19
- 12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
- 13.1 Raw Material of Muscle Relaxers and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Muscle Relaxers
- 13.3 Muscle Relaxers Production Process
- 13.4 Muscle Relaxers Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Muscle Relaxers Typical Distributors
- 14.3 Muscle Relaxers Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
According to our (Global Info Research) latest study, the global Muscle Relaxers market size was valued at USD 4012.9 million in 2022 and is forecast to a readjusted size of USD 5783.2 million by 2029 with a CAGR of 5.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Muscle relaxers (also called muscle relaxants) are prescription medications that affect muscle function. Healthcare providers prescribe them to treat several symptoms, such as muscle spasms, spasticity and musculoskeletal pain.The term “muscle relaxant” refers to two major drug classes: antispastics and antispasmodics. These two classes differ in their uses, ways of working and side effects.
This report is a detailed and comprehensive analysis for global Muscle Relaxers market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Muscle Relaxers market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Muscle Relaxers market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Muscle Relaxers market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Muscle Relaxers market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Muscle Relaxers
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Muscle Relaxers market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novartis, Viatris, Teva Pharmaceuticals, Endo Pharmaceuticals and Mayne Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Muscle Relaxers market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Tablet
Capsule
Market segment by Application
Hospital
Clinic
Pharmacy
Major players covered
Novartis
Viatris
Teva Pharmaceuticals
Endo Pharmaceuticals
Mayne Pharma
Merck & Co. Inc
GSK
Casper Pharma LLC
Bayer
BASF
ADVIL
Pfizer
Johnson & Johnson
Rosemont Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Muscle Relaxers product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Muscle Relaxers, with price, sales, revenue and global market share of Muscle Relaxers from 2018 to 2023.
Chapter 3, the Muscle Relaxers competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Muscle Relaxers breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Muscle Relaxers market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Muscle Relaxers.
Chapter 14 and 15, to describe Muscle Relaxers sales channel, distributors, customers, research findings and conclusion.